Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease

NCT02392780 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Acute-graft-versus-host Disease

Interventions

DRUG: Cannabidiol
DRUG: Methylprednisolone
DRUG: Calcineurin inhibitor

Sponsor

moshe yeshurun